{"issuance_frequency":"","notes_translated":{"fr":"La présente ligne directrice fournit de l'information sur l'interprétation et l'application de l'article 3 et de l'annexe A de la Loi sur les aliments et drogues (LAD), des articles A.01.067 et A.01.068 du Règlement sur les aliments et drogues (RAD), et des articles 103.2 et 103.3 du Règlement sur les produits de santé naturels (RPSN) (en vertu desquels l'interdiction générale prévue dans la Loi sur les aliments et drogues d'utiliser des allégations de prévention à l'égard des maladies répertoriées à l'annexe A ne s'applique pas aux produits de santé naturels (PSN) ni aux médicaments en vente libre).","en":"This guidance provides information relating to the interpretation and enforcement of section 3 and Schedule A to the Food and Drugs Act (FDA), as well as sections A.01.067 and A.01.068 of the Food and Drug Regulations (FDR) and sections 103.2 and 103.3 of the Natural Health Products Regulations (NHPR) (which exempt natural health products (NHPs) and nonprescription drugs from the FDA's general prohibition on labelling and advertising of preventative claims for the diseases listed in Schedule A). "},"issn":"","imso_approval":"true","isbn":"","creator":"","org_section":{"fr":"","en":""},"jurisdiction":"federal","private":false,"maintainer_email":"open-ouvert@tbs-sct.gc.ca","num_tags":0,"edition":"","frequency":"as_needed","data_series_issue_identification":{"fr":"","en":""},"contributor":{"fr":"","en":""},"maintainer":null,"ready_to_publish":"true","id":"79a83689-cd49-44d8-9b76-686492d65fa0","metadata_created":"2021-09-09T12:51:29.816950","subject":["health_and_safety"],"pspc_identification_number":"","metadata_modified":"2021-09-09T12:51:29.816957","author":null,"author_email":null,"geographic_region":[],"portal_release_date":"2021-09-09","digital_object_identifier":"","state":"active","version":null,"keywords":{"fr":["Produits de santé naturels","PSN","Loi sur les aliments et drogues","LAD","annexe A","article 3","Santé Canada 2010","Règlement sur les aliments et drogues","RAD","interprétation et application de l'article 3 et de l'annexe A","Règlement sur les aliments et drogues","RAD","articles A. 01.067 et A.01.068","Règlement sur les produits de santé naturels","RPSN","articles 103.2 et 103.3"],"en":["Natural health products","NHP","Food and Drugs Act","FDA","schedule A","section 3","Health Canada 2010","Food and Drug Regulations","FDR","interpretation and enforcement of section 3 and Schedule A","Food and Drug Regulations","FDR","sections A.01.067 and A.01.068","Natural Health Products Regulations","NHPR","sections 103.2 and 103.3"]},"relationships_as_object":[],"creator_user_id":"2dc5a12f-2a6f-4822-8514-165ea6bb05d9","title_translated":{"fr":"Ligne directrice : Annexe A et article 3 de la Loi sur les aliments et drogues","en":"Guidance Document: Schedule A and Section 3 to the Food and Drugs Act [Health Canada, 2010]"},"type":"info","resources":[{"cache_last_updated":null,"unique_identifier":"","package_id":"79a83689-cd49-44d8-9b76-686492d65fa0","datastore_contains_all_records_of_source_file":false,"datastore_active":false,"character_set":"","related_type":"","state":"active","id":"5bd84ab0-c6d6-4795-ac03-2157d3469468","related_relationship":"","name_translated":{"fr":"Ligne directrice : Annexe A et article 3 de la Loi sur les aliments et drogues","en":"Guidance Document: Schedule A and Section 3 to the Food and Drugs Act [Health Canada, 2010]"},"hash":"","description":"","format":"HTML","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"Guidance Document: Schedule A and Section 3 to the Food and Drugs Act [Health Canada, 2010]","language":["en"],"created":"2021-09-09T12:51:29.896406","url":"https://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/applications-submissions/guidance-documents/guidance-document-schedule-section-3-food-drugs-act.html","last_modified":null,"position":0,"revision_id":"9411b4ea-61f4-43c7-9a6a-95b5b99feb7d","resource_type":"publication"},{"cache_last_updated":null,"unique_identifier":"","package_id":"79a83689-cd49-44d8-9b76-686492d65fa0","datastore_contains_all_records_of_source_file":false,"datastore_active":false,"character_set":"","related_type":"","state":"active","id":"8ca38fa2-c13a-44d5-af95-62225c05424f","related_relationship":"","name_translated":{"fr":"Ligne directrice : Annexe A et article 3 de la Loi sur les aliments et drogues","en":"Guidance Document: Schedule A and Section 3 to the Food and Drugs Act [Health Canada, 2010]"},"hash":"","description":"","format":"HTML","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"Guidance Document: Schedule A and Section 3 to the Food and Drugs Act [Health Canada, 2010]","language":["fr"],"created":"2021-09-09T12:51:29.896412","url":"https://www.canada.ca/fr/sante-canada/services/medicaments-produits-sante/medicaments/demandes-presentations/lignes-directrices/annexe-article-3-loi-aliments-drogues.html","last_modified":null,"position":1,"revision_id":"9411b4ea-61f4-43c7-9a6a-95b5b99feb7d","resource_type":"publication"}],"place_of_publication":[],"num_resources":2,"tags":[],"spatial":"","collection":"publication","org_title_at_publication":{"fr":"Santé Canada","en":"Health Canada"},"date_published":"2017-05-18 00:00:00","issuance":"","groups":[],"license_id":"ca-ogl-lgo","data_series_name":{"fr":"","en":""},"relationships_as_subject":[],"license_title":"Open Government Licence - Canada","restrictions":"unrestricted","organization":{"description":"","created":"2016-09-23T17:25:33.001625","title":"Health Canada | Santé Canada","name":"hc-sc","is_organization":true,"state":"active","image_url":"","revision_id":"6a0471e8-36e5-4217-8f72-563c83e6465a","type":"organization","id":"BD26DB5E-82D2-42C1-99BB-08FCF6068FEE","approval_status":"approved"},"name":"79a83689-cd49-44d8-9b76-686492d65fa0","isopen":false,"additional_notes":{"fr":"","en":""},"departmental_identification_number":"","notes":"This guidance provides information relating to the interpretation and enforcement of section 3 and Schedule A to the Food and Drugs Act (FDA), as well as sections A.01.067 and A.01.068 of the Food and Drug Regulations (FDR) and sections 103.2 and 103.3 of the Natural Health Products Regulations (NHPR) (which exempt natural health products (NHPs) and nonprescription drugs from the FDA's general prohibition on labelling and advertising of preventative claims for the diseases listed in Schedule A). ","owner_org":"BD26DB5E-82D2-42C1-99BB-08FCF6068FEE","program_page_url":{"fr":"","en":""},"url":null,"audience":[],"gc_catalogue_number":"","license_url":"http://open.canada.ca/en/open-government-licence-canada","series_publication_dates":{"fr":"","en":""},"title":"Guidance Document: Schedule A and Section 3 to the Food and Drugs Act [Health Canada, 2010]","revision_id":"9411b4ea-61f4-43c7-9a6a-95b5b99feb7d"}